RecruitingPhase 4NCT06013956

Personalized Real-Time DBS and PD Mechanisms

Identifying Circuit Dynamics Underlying Motor Dysfunction in Parkinson's Disease Using Real-Time Neural Control


Sponsor

David Escobar

Enrollment

25 participants

Start Date

Aug 29, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

A prospective cohort of patients scheduled to undergo deep brain stimulation (DBS) implantation surgery for the treatment of Parkinson's disease as per standard of care will be invited to participate in this study. This mechanistic study is aimed at better understanding the role of basal ganglia beta band (11-35 Hz) oscillations and resonance in the manifestation of Parkinson's disease (PD) motor signs using closed-loop electrical neurostimulation, levodopa medication, and computational modeling. The ultimate goal of this study is to inform the development of closed-loop neuromodulation technology that can be programmed and adjusted in real time based on patient-specific neural activity.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria4

  • Ability to provide informed consent.
  • Clinical diagnosis of idiopathic Parkinson's disease.
  • Determined, as per standard of care, to be a candidate for deep brain stimulation (DBS) surgery targeting the subthalamic nucleus.
  • Ability to tolerate delays in taking daily standard Parkinson's disease medications.

Exclusion Criteria2

  • Secondary Parkinsonism, stroke, or progressive central nervous system disease other than Parkinson's disease.
  • Patient has a condition that, in the opinion of the investigators, would significantly increase the risk of interfering with study compliance, safety, or outcome.

Interventions

DEVICENeurostimulation

Electrical stimulation delivered via deep brain stimulation electrodes based on measurements of brain activity.

DRUGCarbidopa 25/Levodopa 100Mg Tab

Anti-parkinsonian medication.


Locations(1)

Cleveland Clinic

Cleveland, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06013956


Related Trials